Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Cisplatin + Fluorouracil (5-FU) + Pembrolizumab & Gastroesophageal junction adenocarcinoma (GEJ), Pembrolizumab is FDA‑approved for advanced/metastatic gastric and Gastroesophageal junction adenocarcinoma (GEJ) in combination with fluoropyrimidine‑ and platinum‑containing chemotherapy (e.g., Cisplatin + Fluorouracil (5-FU) + Pembrolizumab) as first‑line treatment (1, 2)
Pembrolizumab in combination with fluoropyrimidine‑ and platinum‑based chemotherapy (e.g., [Cisplatin + Fluorouracil (5-FU) + Pembro…